Sailike Bayan, Omarova Zhannur, Jenis Janar, Adilbayev Altynay, Akbay Burkitkan, Askarova Sholpan, Jin Wei-Lin, Tokay Tursonjan
Biology Department, School of Sciences and Humanities, Nazarbayev University, Nur-Sultan, Kazakhstan.
Research Center for Medicinal Plants of Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Front Pharmacol. 2022 Oct 19;13:1021501. doi: 10.3389/fphar.2022.1021501. eCollection 2022.
The Genus Artemisia L. is one of the largest genera in the Asteraceae family growing wild over in Europe, North America, and Central Asia and has been widely used in folk medicine for the treatment of various ailments. Phytochemical and psychopharmacological studies indicated that the genus Artemisia extracts contain various antioxidant and anti-inflammatory compounds and possess antioxidant, anti-inflammatory, antimicrobial, antimalarial, and antitumor activity. Recently, increasing experimental studies demonstrated that many Artemisia extracts offer a great antiepileptic potential, which was attributed to their bioactive components various mechanisms of action. However, detailed literature on the antiepileptic properties of the genus Artemisia and its mechanism of action is segregated. In this review, we tried to gather the detailed neuroprotective and antiepileptic properties of the genus Artemisia and its possible underlying mechanisms. In this respect, 63 articles were identified in the PubMed and Google scholars databases, from which 18 studies were examined based on the pharmacological use of the genus Artemisia species in epilepsy. The genus Artemisia extracts have been reported to possess antioxidant, anti-inflammatory, neurotransmitter-modulating, anti-apoptotic, anticonvulsant, and pro-cognitive properties by modulating oxidative stress caused by mitochondrial ROS production and an imbalance of antioxidant enzymes, by protecting mitochondrial membrane potential required for ATP production, by upregulating GABA-A receptor and nACh receptor activities, and by interfering with various anti-inflammatory and anti-apoptotic signaling pathways, such as mitochondrial apoptosis pathway, ERK/CREB/Bcl-2 pathway and Nrf2 pathway. This review provides detailed information about some species of the genus Artemisia as potential antiepileptic agents. Hence, we recommend further investigations on the purification and identification of the most biological effective compounds of Artemisia and the mechanisms of their action to cure epilepsy and other neurological diseases.
蒿属植物是菊科中最大的属之一,在欧洲、北美和中亚广泛野生,并且在民间医学中已被广泛用于治疗各种疾病。植物化学和精神药理学研究表明,蒿属植物提取物含有多种抗氧化和抗炎化合物,并具有抗氧化、抗炎、抗菌、抗疟疾和抗肿瘤活性。最近,越来越多的实验研究表明,许多蒿属植物提取物具有很大的抗癫痫潜力,这归因于它们的生物活性成分及其多种作用机制。然而,关于蒿属植物抗癫痫特性及其作用机制的详细文献是分散的。在本综述中,我们试图收集蒿属植物详细的神经保护和抗癫痫特性及其可能的潜在机制。在这方面,在PubMed和谷歌学术数据库中鉴定出63篇文章,其中18项研究基于蒿属植物在癫痫中的药理用途进行了审查。据报道,蒿属植物提取物通过调节线粒体ROS产生和抗氧化酶失衡引起的氧化应激、保护ATP产生所需的线粒体膜电位、上调GABA - A受体和nACh受体活性以及干扰各种抗炎和抗凋亡信号通路,如线粒体凋亡通路、ERK/CREB/Bcl - 2通路和Nrf2通路,而具有抗氧化、抗炎、神经递质调节、抗凋亡、抗惊厥和促认知特性。本综述提供了关于蒿属植物某些物种作为潜在抗癫痫药物的详细信息。因此,我们建议进一步研究蒿属植物最具生物活性的化合物及其作用机制,以治疗癫痫和其他神经系统疾病。